RAJEEV ET AL.
43
[2] S. Jagadish, M. Hemshekhar, S. K. Naveen Kumar, K. S.
Sharath Kumar, M. S. Sundaram, K. S. Girish, K. S. Rangappa,
Toxicol. Appl. Pharmacol. 2017, 334, 167.
[3] S. Jagadish, N. Rajeev, S. K. Naveen Kumar, K. S. Sharath
Kumar, M. Manoj Paul, M. P. Hegde, K. S. Sadashiva, K. S. R.
Girish, Mol. Cell. Biochem. 2016, 414, 137.
[4] N. Snehal, M. Raghunandan, K. Jinsha, K. S. Sujeeth Kumar,
G. Sharath Kumar, S. S. S. K. Vidya, B. Choudhary, Molecules
2020, 25, 4499.
concentrated under reduced pressure to get crude prod-
ucts, which were purified by column chromatography
using 10% ethyl acetate in hexane.
3.1 | Anti-TB activity using Alamar
blue dye
[5] S. Ding, N. S. Gray, X. Wu, Q. Ding, P. G. Schultz, J. Am.
Chem. Soc. 2002, 124, 1594.
The antimycobacterial activity of compounds was
screened for M. tuberculosis (H37 RV strain), ATCC No-
27294, using microplate Alamar Blue assay (MABA). For
the outer perimeter of the well in 96 well plate, 200 μl of
sterile deionized water was added (to minimized evapora-
tion of medium in the test wells during incubation),
100 μl of the Middlebrook 7H9 broth, and serial two-fold
dilution of synthesized compounds were added to the
each well (100–0.2 μg/ml). After addition, plates were
covered and sealed with parafilm and incubated at 37ꢀC
for 5 days. Once completion of the incubation, added
25 μl of freshly prepared 1:1 mixture of Almar Blue
reagent and 10% tween 80 to the plate and incubated for
24 hr at the same temperature. The appearance of the
blue color in the well indicated as no bacterial growth
and appeared pink color as growth. The lowest concen-
tration of drug, which prevented the color change from
blue to pink was defined as MIC of the compound.
[6] K. Wang, D. Kim, A. Domling, J. Comb. Chem. 2010, 12, 111.
[7] M. C. Bryan, B. Dillon, L. G. Hamann, G. J. Hughes, M. E.
Kopach, E. A. Peterson, M. Pourashraf, I. Raheem, P.
Richardson, D. Richter, H. F. Sneddon, J. Med. Chem. 2013,
56, 6007.
[8] S. Hanessian, E. Stoffman, X. Mi, P. Renton, Org. Lett. 2011,
13, 840.
[9] A. Andreani, M. Rambaldi, J. Het. Chem. 1988, 25, 1519.
[10] X. Zhang, T. Mu, F. Zhan, L. Ma, G. Liang, Angew. Chem.
2011, 50, 6164.
[11] S. Mostafa, M. Adel, K. El-Dean, A. Mostafa, H. Reda, J. Chin.
Chem. Soc. 2019, 66, 218.
[12] K. K. Lo, K. H. Tsang, W. K. Hui, N. Zhu, Chem. Commun.
2003, 2704.
[13] WHO, Global Tuberculosis Report, World Health Organization,
Geneva, Switzerland 2017.
[14] D. A. Negatu, J. J. J. Liu, M. Zimmerman, F. Kaya, V. Dartois,
C. C. Aldrich, M. Gengenbacher, T. Dick, Antimicrob. Agents
Chemother. 2018, 62, e01571.
[15] Y. Oikawa, H. Hirasawa, O. Yonemitsu, Tetrahedron Lett.
1978, 19, 1759.
[16] Y. Oikawa, H. Hirasawa, O. Yonemitsu, Chem. Pharm. Bull.
1982, 30, 3092.
4 | CONCLUSIONS
In conclusion, we have demonstrated a straight forward,
mild and high yielding protocol for the synthesis of 3-indole
propanoates/propanoic acid/propanamides. The main
advantages of this protocol are one-pot operation and the
reaction does not demand a catalyst or additive to accelerate
the decarboxylation process to produce the title compounds.
All the compounds are evaluated for their antitubercular
activity against Mycobacterium tuberculosis H37Rv stain.
Among the compounds, 4d was found to be a more potent
than the standards with MIC of 1.6 μg/ml. These molecules
open a new avenue for the development of active anti-TB
drug candidates in the future.
[17] L. J. Pollock, I. Finkelman, A. J. Arieff, Arch. Intern. Med.
1943, 71, 95.
[18] A. Schatz, R. Rasappan, M. Hager, A. Gissibl, O. Reiser, Chem-
istry 2008, 14, 7259.
[19] W. Zhuang, T. Hansen, K. A. Jorgensen, Chem. Commun.
2001, 347.
[20] J. Wu, D. Wang, F. Wu, B. Wan, J. Org. Chem. 2013, 78,
5611.
[21] J. Zhou, M. C. Ye, Z. Z. Huang, Y. Tang, J. Org. Chem. 2004,
69, 1309.
[22] M. C. Ye, B. Li, J. Zhou, X. L. Sun, Y. Tang, J. Org. Chem.
2005, 70, 6108.
[23] Y. Liu, D. Shang, X. Zhou, X. Liu, X. Feng, Chemistry 2009, 15,
2055.
[24] E. L. Armstrong, H. K. Grover, M. A. Kerr, J. Org. Chem. 2013,
78, 10534.
ACKNOWLEDGMENTS
All authors are grateful to the Institute of excellence,
University of Mysore, Mysuru for spectral analysis. MPS
thanks UGC-SAP-DRS-III for financial assistance.
[25] J. Oelerich, G. Roelfes, Org. Biomol. Chem. 2015, 13, 2793.
[26] Y. Liu, X. Zhou, D. Shang, X. Liu, X. Feng, Tetrahedron 2010,
66, 1447.
[27] A. Viola, L. Ferrazzano, G. Martelli, S. Ancona, L. Gentilucci,
A. Tolomelli, Tetrahedron 2014, 70, 6781.
[28] B. Mohammad, K. Ali, B. Zohreh, T. Zahara, M. Mohamad,
J. Chin. Chem. Soc. 2019, 66, 674.
[29] J. Zhou, Y. Tang, J. Am. Chem. Soc. 2002, 124, 9030.
[30] P. K. Singh, V. K. Singh, Org. Lett. 2008, 10, 4121.
REFERENCES
[1] K. S. Sharath Kumar, A. Hanumappa, M. Hegde, K. H.
Narasimhamurthy, S. C. Raghavan, K. S. Rangappa, Eur.
J. Med. Chem. 2014, 81, 341.